BACKGROUND AND AIMS: Fatty liver may have different determinants in normal-weight and in obese individuals. We measured factors associated with fatty liver in 863 normal-weight (BMI < 25) and 1135 overweight/obese (BMI ≥ 25) young and middle-aged adults (45% male, age 34-49 years) in the population-based Cardiovascular Risk in Young Finns Study. METHODS AND RESULTS: The prevalence of fatty liver detected with ultrasound was 29% in overweight/obese and 5% in normal-weight participants. In overweight/obese, the independent correlates were waist circumference (odds ratio for 1 standard deviation increase = 3.78), alanine transaminase (2.11), BMI (2.00), male sex (1.74), triglycerides (1.44), systolic blood pressure (1.31), fasting insulin (1.23), and physical activity (0.76). In normal weight, the independent correlates included alanine transaminase (3.05), smoking (2.56), systolic blood pressure (1.54), and alcohol intake (1.41). In normal-weight participants, the associations with fatty liver were stronger for alcohol intake and smoking, and weaker for triglycerides, than in overweight/obese participants (P for interaction < 0.05). CONCLUSION: Prevalence of fatty liver was 29% in overweight/obese and 5% in normal-weight adults. Differences in factors associated with fatty liver were seen between these two groups: alcohol intake and smoking were more strongly and triglycerides more weakly associated in normal-weight than in overweight/obese participants.
BACKGROUND AND AIMS: Fatty liver may have different determinants in normal-weight and in obese individuals. We measured factors associated with fatty liver in 863 normal-weight (BMI < 25) and 1135 overweight/obese (BMI ≥ 25) young and middle-aged adults (45% male, age 34-49 years) in the population-based Cardiovascular Risk in Young Finns Study. METHODS AND RESULTS: The prevalence of fatty liver detected with ultrasound was 29% in overweight/obese and 5% in normal-weight participants. In overweight/obese, the independent correlates were waist circumference (odds ratio for 1 standard deviation increase = 3.78), alanine transaminase (2.11), BMI (2.00), male sex (1.74), triglycerides (1.44), systolic blood pressure (1.31), fasting insulin (1.23), and physical activity (0.76). In normal weight, the independent correlates included alanine transaminase (3.05), smoking (2.56), systolic blood pressure (1.54), and alcohol intake (1.41). In normal-weight participants, the associations with fatty liver were stronger for alcohol intake and smoking, and weaker for triglycerides, than in overweight/obeseparticipants (P for interaction < 0.05). CONCLUSION: Prevalence of fatty liver was 29% in overweight/obese and 5% in normal-weight adults. Differences in factors associated with fatty liver were seen between these two groups: alcohol intake and smoking were more strongly and triglycerides more weakly associated in normal-weight than in overweight/obeseparticipants.
Entities:
Keywords:
Cohort studies; epidemiologic factors; fatty liver; normal body weight; overweight; prevalence
Authors: Emma Raitoharju; Ilkka Seppälä; Leo-Pekka Lyytikäinen; Jorma Viikari; Mika Ala-Korpela; Pasi Soininen; Antti J Kangas; Melanie Waldenberger; Norman Klopp; Thomas Illig; Jaana Leiviskä; Britt-Marie Loo; Niku Oksala; Mika Kähönen; Nina Hutri-Kähönen; Reijo Laaksonen; Olli Raitakari; Terho Lehtimäki Journal: Sci Rep Date: 2016-12-05 Impact factor: 4.379
Authors: Jari E Kaikkonen; Peter Würtz; Emmi Suomela; Miia Lehtovirta; Antti J Kangas; Antti Jula; Vera Mikkilä; Jorma S A Viikari; Markus Juonala; Tapani Rönnemaa; Nina Hutri-Kähönen; Mika Kähönen; Terho Lehtimäki; Pasi Soininen; Mika Ala-Korpela; Olli T Raitakari Journal: Hepatology Date: 2016-12-24 Impact factor: 17.425
Authors: Eline H van den Berg; Marzyeh Amini; Tim C M A Schreuder; Robin P F Dullaart; Klaas Nico Faber; Behrooz Z Alizadeh; Hans Blokzijl Journal: PLoS One Date: 2017-02-02 Impact factor: 3.240
Authors: Eeva Sliz; Sylvain Sebert; Peter Würtz; Antti J Kangas; Pasi Soininen; Terho Lehtimäki; Mika Kähönen; Jorma Viikari; Minna Männikkö; Mika Ala-Korpela; Olli T Raitakari; Johannes Kettunen Journal: Hum Mol Genet Date: 2018-06-15 Impact factor: 6.150
Authors: Francesco Giuseppe Foschi; Giorgio Bedogni; Marco Domenicali; Pierluigi Giacomoni; Anna Chiara Dall'Aglio; Francesca Dazzani; Arianna Lanzi; Fabio Conti; Sara Savini; Gaia Saini; Mauro Bernardi; Pietro Andreone; Amalia Gastaldelli; Andrea Casadei Gardini; Claudio Tiribelli; Stefano Bellentani; Giuseppe Francesco Stefanini Journal: BMC Gastroenterol Date: 2018-11-28 Impact factor: 3.067